Actively Recruiting
Intra-articular Corticosteroid Injection in GAE for Knee Knee Osteoarthritis
Led by Zagazig University · Updated on 2024-10-01
60
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to investigate the effectiveness and safety of intra-articular corticosteroid injection (IACI) in alleviating post-procedural pain and improving early outcomes in patients undergoing geniculate artery embolization (GAE) for knee osteoarthritis (OA). The main questions it aims to answer are: * Does intra-articular corticosteroid injection reduce pain levels post-procedure compared to GAE alone? * Does the combination of GAE and IACI improve functional outcomes and patient-reported outcomes compared to GAE alone? Investigators will compare patients receiving GAE with IACI to those receiving GAE alone to see if the addition of IACI provides superior pain relief and functional improvement. Participants will: * Undergo geniculate artery embolization, with or without intra-articular corticosteroid injection. * Have their pain levels assessed using the Visual Analog Scale (VAS) at 1 week, 2 weeks, and 4 weeks post-procedure. * Complete functional outcome assessments using the KOOS and WOMAC scores. * Report any adverse events throughout the study period.
CONDITIONS
Official Title
Intra-articular Corticosteroid Injection in GAE for Knee Knee Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and older
- Diagnosed with knee osteoarthritis (OA) based on clinical and radiographic criteria.
- Eligible for geniculate artery embolization (GAE) as determined by the treating physician.
- Able to provide informed consent and comply with the study protocol.
You will not qualify if you...
- Contraindications to corticosteroid injections or geniculate artery embolization.
- Pregnant or breastfeeding women.
- Active infection or skin condition at the injection site.
- Severe cardiovascular, renal, or hepatic diseases that may affect study participation.
- Previous knee surgery within the last 6 months.
- Participation in another clinical trial within the last 30 days.
- Inability to comply with follow-up visits or complete study assessments.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zagazig University, Faculty of Medicine
Zagazig, Egypt, 44519
Actively Recruiting
Research Team
A
Ahmed A Bessar, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here